Our foundation, through its partnerships with AmeriCares and Abbvie Laboratories, delivers Survanta medication to Neonatology Unit within University Clinical Center of Kosovo since 2009.

Without enough surfactant, the lungs collapse and premature babies die. Infants who experience respiratory distress lack sufficient amounts of surfactant – the liquid coats inside the lungs. Babies usually don’t start producing surfactant until a few weeks after they are born. Without enough surfactant the lungs collapse and premature babies cannot breathe. Thus, Survanta is vital for prevention and treatment of RDS (Respiratory Distress Syndrome) and reduces the mortality rate caused by RDS.

We secure Survanta medication, through our partnerships with AmeriCares, since 2009.

Below is the list of donations made to Neonatology Unit since 2009:

FACT: Lives of around 1800 babies in Kosovo have been saved as a result of using Survanta medication.